Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care

About this update from Bausch + Lomb Corporation

VAUGHAN, Ontario, & MENLO PARK, Calif., July 09, 2026--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the creation of Orphia™, a new AI-powered digital health platform built on the belief that eye care providers should spend less time managing disconnected tools and technologies and more time caring for patients. The platform is brand agnostic and designed to serve all eye care providers, regardless of the products, devices or treatments they choose to use. Orphia will operate under Digital Health Services, a newly created platform at Bausch + Lomb. The first application of the Orphia digital health platform focuses on pre-surgery cataract education, helping patients understand their condition and treatment options, identifying concerns and preparing them before they meet with their surgeon. The goal is not simply to answer questions. It is to ensure patients arrive informed and ready, so conversations with their surgeon are more meaningful, allowing physicians to focus on what matters most: achieving the best possible outcome for each patient's vision. To assist with the development of conversational patient engagement capability, Bausch + Lomb has engaged Hippocratic AI, a leader in voice AI agents for healthcare and life sciences, with a proprietary LLM built on more than 200 million real patient interactions, validated by more 7500 U.S.-licensed clinicians, and a track record of deployment across major health systems and health care organizations nationwide. "We've invested deeply in developing better products, better molecules and better devices, and that work has advanced patient care. But one question has remained largely unanswered: How can we help physicians spend less time on everything around care and more time delivering it?" said Brent Saunders, Chairman and CEO, Bausch + Lomb. "Orphia was created to serve every eye care provider, no matter what they prescribe or what product they use." Orphia is designed to integrate with the systems that practices already use, complementing existing workflows and creating actionable insights for clinical teams. Over time, Bausch + Lomb plans to expand the platform's capabilities to support the full patient journey, from care coordination to practice workflow, reducing the operational ...

View stock analysis, news, and events for Bausch + Lomb Corporation